Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Fehm, T. N.; Bruckner, S.; Huebner, H. et al.
CAPTOR-BC - Comprehensive analysis of spatial, temporal and molecular biomarkers predicting response and resistance to first-line treatment with ribociclib plus ET in HR+, HER2-advanced breast cancerONCOLOGY RESEARCH AND TREATMENT. Bd. 46. 2023 S. 171-172
Hoeffken, Klaus; Bruns, Christiane; Schmidberger, Heinz
Carcinogenesis revisitedONKOLOGIE. Bd. 29. H. 3. 2023 S. 246-246
Craddock, Matthew; Nestle, Ursula; Koenig, Jochem et al.
Cardiac Function Modifies the Impact of Heart Base Dose on Survival: A Voxel-Wise Analysis of Patients With Lung Cancer From the PET-Plan TrialJOURNAL OF THORACIC ONCOLOGY. Bd. 18. H. 1. 2023 S. 57-66
Urmann, Emanuel; Stamm, Paul; Wisskirchen, Jonas
Cefiderocol in AML patient with neutropenic infection due to 4MRGN Klebsiella pneumoniae (VIM-1)DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 148. H. 04. 2023 S. 170-174
Bostel, Tilman; Akbaba, Sati; Wollschlaeger, Daniel et al.
Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderlyFRONTIERS IN ONCOLOGY. Bd. 13. 2023
Penson, A.; Walraven, I.; Bronkhorst, E. et al.
Chronic fatigue in childhood cancer survivors is associated with lifestyle and psychosocial factors; a DCCSS LATER studyESMO OPEN. Bd. 8. H. 6. 2023
Mackensen, Andreas; Haanen, John B. A. G.; Koenecke, Christian et al.
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trialNATURE MEDICINE. 2023
Novak, Urban; Fehr, Martin; Schaer, Saemi et al.
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13)ECLINICALMEDICINE. Bd. 64. 2023
Albendea, Miguel A. Canales; Canonico, Pier Luigi; Cartron, Guillaume et al.
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countriesFRONTIERS IN MEDICINE. Bd. 10. 2023
Duque-Afonso, Jesus; Finke, Juergen; Ngoya, Maud et al.
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working PartyBONE MARROW TRANSPLANTATION. 2023